Drug companies are unambiguously out of control. Some of these new molecules don't even need to be invented, they're just legally distinct repackaging of something they can't gouge on anymore. These companies could, if they had an incentive to do so, research effective off-label uses of existing drugs, say. But there's no money in that. There is a ton of money in making legally distinct "new" drugs that do the same thing as newly-generic drugs. It's unacceptable what they get away with.
Covid ought to have been the final straw that brought all sides together to do something about drug companies.
replies(5):